Takayuki Kato

Atami, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Surgical Resection of an Ascending Colon Tumor Suspected to Represent Intestinal Behçet's Disease-A Case Report

Surgical Resection of an Ascending Colon Tumor Suspected to Represent Intestinal Behçet's Disease-A Case Report

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: October 27, 2025

Bifidobacterium bifidum G9-1 and Quality of Life in Chronic Constipation: A Multicenter, Double-Blind, Randomized Controlled Trial.

Bifidobacterium bifidum G9-1 and Quality of Life in Chronic Constipation: A Multicenter, Double-Blind, Randomized Controlled Trial.

Journal: Digestion

Published: August 24, 2025

Therapeutic Impact on Quality of Life in Adult Patients With Chronic Intestinal Pseudo-obstruction: A Multicenter, Cohort Study.

Therapeutic Impact on Quality of Life in Adult Patients With Chronic Intestinal Pseudo-obstruction: A Multicenter, Cohort Study.

Journal: Journal of neurogastroenterology and motility

Published: June 05, 2025

Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrations.

Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrations.

Journal: Frontiers in medicine

Published: November 24, 2024

The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms.

The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms.

Journal: Journal of neurogastroenterology and motility

Published: September 20, 2022

Successful resection of a 16-cm half-circumferential lesion at the greater curvature of the stomach using the endoscopic submucosal large-tunnel method.

Successful resection of a 16-cm half-circumferential lesion at the greater curvature of the stomach using the endoscopic submucosal large-tunnel method.

Journal: Endoscopy

Published: July 01, 2022

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation.

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation.

Journal: BMJ open

Published: May 31, 2022

Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial.

Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial.

Journal: Cancers

Published: April 03, 2022

Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs.

Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs.

Journal: Diagnostics (Basel, Switzerland)

Published: October 08, 2020

The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin.

The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin.

Journal: Gut microbes

Published: June 10, 2020

Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial.

Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial.

Journal: The lancet. Gastroenterology & hepatology

Published: March 14, 2020

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study.

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study.

Journal: Trials

Published: August 05, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026